| Date | Form | Description | Docs | XBRL | Pages |
| 04/05/17 | 8-K | Current report filing |
|
4 | |
| 04/04/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/03/17 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 | |
| 03/27/17 | RW | Registration Withdrawal Request |
|
1 | |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 | |
| 02/01/17 | CT ORDER | Confidential treatment order |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...